Haemonetics GmbH Files Infringement Suit to Defend its Plasma Technology
		Munich, Germany, Feb. 23, 2010 – Haemonetics GmbH (NYSE: HAE) today announced that it has filed a legal action against Stradis-Med GmbH and its General Manager, Jochen Kirschner for infringement of two Haemonetics utility models (DE 200 10 825 U1 and DE 203 10 937 U1) related to its proprietary plasma technology. Haemonetics seeks to stop Stradis-Med GmbH and Mr. Kirschner from selling plasma bottles that Haemonetics alleges are infringing its utility models. The plasma bottles in question are apparently supplied by Chinese manufacturer Nigale.    Mikael Gordon, President Haemonetics Global Markets said, "Haemonetics will continue to invest significantly to develop new technologies and blood management offerings for our customers. The protection of our intellectual property is essential; for it is the foundation of our business."     Haemonetics has a history of creating innovative devices and solutions that have changed the way blood is collected and processed.     Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.    Haemonetics GmbH is the German head quarters of Haemonetics Corporation. Haemonetics' European headquarters are located in Signy, Switzerland.    Contact: Bryanne Salmon   Tel. (781) 356-9613